James Hambro & Partners LLP lifted its stake in shares of AMETEK, Inc. (NYSE:AME – Free Report) by 77.2% during the fourth quarter, Holdings Channel reports. The firm owned 621,355 shares of the technology company’s stock after buying an additional 270,764 shares during the period. AMETEK comprises about 4.4% of James Hambro & Partners LLP’s holdings, making the stock its 13th largest position. James Hambro & Partners LLP’s holdings in AMETEK were worth $112,033,000 as of its most recent SEC filing.
Several other hedge funds have also made changes to their positions in AME. KBC Group NV boosted its stake in AMETEK by 66.8% during the 4th quarter. KBC Group NV now owns 261,206 shares of the technology company’s stock valued at $47,085,000 after purchasing an additional 104,603 shares during the period. AlphaMark Advisors LLC raised its holdings in shares of AMETEK by 2.1% during the fourth quarter. AlphaMark Advisors LLC now owns 3,348 shares of the technology company’s stock valued at $604,000 after buying an additional 70 shares during the last quarter. Running Oak Capital LLC boosted its position in shares of AMETEK by 4.5% during the fourth quarter. Running Oak Capital LLC now owns 77,647 shares of the technology company’s stock worth $13,997,000 after buying an additional 3,356 shares during the period. Fenimore Asset Management Inc grew its holdings in AMETEK by 0.4% in the 4th quarter. Fenimore Asset Management Inc now owns 272,869 shares of the technology company’s stock worth $49,187,000 after buying an additional 993 shares in the last quarter. Finally, Geneos Wealth Management Inc. increased its position in AMETEK by 42.9% in the 4th quarter. Geneos Wealth Management Inc. now owns 233 shares of the technology company’s stock valued at $42,000 after acquiring an additional 70 shares during the period. Institutional investors own 87.43% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on the company. StockNews.com cut AMETEK from a “buy” rating to a “hold” rating in a research note on Friday, January 17th. BNP Paribas upgraded shares of AMETEK from a “neutral” rating to an “outperform” rating and set a $210.00 target price for the company in a research report on Thursday, January 16th. Mizuho raised their target price on shares of AMETEK from $190.00 to $200.00 and gave the company an “outperform” rating in a research note on Friday, November 1st. Truist Financial upped their price target on shares of AMETEK from $221.00 to $222.00 and gave the stock a “buy” rating in a research note on Thursday, January 16th. Finally, KeyCorp raised their price objective on shares of AMETEK from $205.00 to $215.00 and gave the company an “overweight” rating in a research note on Friday, November 22nd. One analyst has rated the stock with a sell rating, three have issued a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $203.44.
Insider Buying and Selling
In other news, insider Emanuela Speranza sold 6,747 shares of the firm’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $195.90, for a total value of $1,321,737.30. Following the completion of the sale, the insider now owns 30,460 shares of the company’s stock, valued at $5,967,114. This trade represents a 18.13 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider David F. Hermance sold 6,243 shares of the stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $190.99, for a total value of $1,192,350.57. Following the completion of the sale, the insider now directly owns 36,731 shares of the company’s stock, valued at approximately $7,015,253.69. This represents a 14.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 29,200 shares of company stock valued at $5,707,620. 0.61% of the stock is owned by corporate insiders.
AMETEK Stock Down 1.3 %
NYSE AME opened at $187.91 on Monday. The company has a market capitalization of $43.47 billion, a P/E ratio of 32.74, a PEG ratio of 2.73 and a beta of 1.16. AMETEK, Inc. has a 12 month low of $149.03 and a 12 month high of $198.33. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.39 and a quick ratio of 0.84. The company’s 50 day simple moving average is $186.47 and its 200 day simple moving average is $176.00.
AMETEK (NYSE:AME – Get Free Report) last announced its quarterly earnings data on Thursday, October 31st. The technology company reported $1.66 EPS for the quarter, beating analysts’ consensus estimates of $1.62 by $0.04. The company had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.71 billion. AMETEK had a return on equity of 16.88% and a net margin of 19.27%. The company’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.64 EPS. Equities research analysts expect that AMETEK, Inc. will post 6.8 earnings per share for the current fiscal year.
AMETEK Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, December 20th. Investors of record on Friday, December 6th were given a $0.28 dividend. The ex-dividend date of this dividend was Friday, December 6th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 0.60%. AMETEK’s dividend payout ratio (DPR) is 19.51%.
About AMETEK
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Read More
- Five stocks we like better than AMETEK
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- The 3 Biggest M&A Stock Opportunities for 2025
- What is the Shanghai Stock Exchange Composite Index?
- A Pivotal Moment for the Consumer Discretionary Sector
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- How Mixed Analyst Opinions Are Shaping Apple Stock’s Outlook
Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME – Free Report).
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.